131 related articles for article (PubMed ID: 8002335)
1. [Drug resistance of malignant melanoma. Mechanisms and possible modulation].
Schadendorf D; Czarnetzki BM
Hautarzt; 1994 Oct; 45(10):678-84. PubMed ID: 8002335
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein expression in primary and metastatic malignant melanoma.
Schadendorf D; Herfordt R; Czarnetzki BM
Br J Dermatol; 1995 Apr; 132(4):551-5. PubMed ID: 7748745
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.
Ichihashi N; Kitajima Y
Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532
[TBL] [Abstract][Full Text] [Related]
4. The chemoresistance of human malignant melanoma: an update.
Serrone L; Hersey P
Melanoma Res; 1999 Feb; 9(1):51-8. PubMed ID: 10338334
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
Yu DS; Ma CP; Chang SY
Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
[TBL] [Abstract][Full Text] [Related]
6. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
7. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
[TBL] [Abstract][Full Text] [Related]
8. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
9. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
10. [Multiple drug resistance: a problem in cancer chemotherapy].
Lizano Soberón M; Barrera Rodríquez R
Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
[TBL] [Abstract][Full Text] [Related]
11. Expression of resistance-related proteins in nephroblastoma after chemotherapy.
Volm M; Mattern J; Stammler G; Royer-Pokora B; Schneider S; Weirich A; Ludwig R
Int J Cancer; 1995 Oct; 63(2):193-7. PubMed ID: 7591203
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
Galimberti S; Nagy B; Benedetti E; Pacini S; Brizzi S; Caracciolo F; Papineschi F; Ciabatti E; Guerrini F; Fazzi R; Canestraro M; Petrini M
Leuk Lymphoma; 2007 Aug; 48(8):1502-9. PubMed ID: 17701580
[TBL] [Abstract][Full Text] [Related]
15. In-vitro study of the influence of octocrylene on a selected metastatic melanoma cell line.
Prunk Zdravković T; Zdravković B; Zdravković M; Dariš B; Lunder M; Ferk P
G Ital Dermatol Venereol; 2019 Apr; 154(2):197-204. PubMed ID: 28704989
[TBL] [Abstract][Full Text] [Related]
16. Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf D; Makki A; Stahr C; van Dyck A; Wanner R; Scheffer GL; Flens MJ; Scheper R; Henz BM
Am J Pathol; 1995 Dec; 147(6):1545-52. PubMed ID: 7495278
[TBL] [Abstract][Full Text] [Related]
17. Expression of glutathione transferase pi in benign and malignant lesions of the melanocyte lineage.
Natali PG; Nicotra MR; Citro G; Cucco C; Bigotti A; Kantor RR
Melanoma Res; 1992 Nov; 2(4):219-23. PubMed ID: 1362663
[TBL] [Abstract][Full Text] [Related]
18. A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours.
Mousseau M; Chauvin C; Nissou MF; Chaffanet M; Plantaz D; Pasquier B; Schaerer R; Benabid A
Eur J Cancer; 1993; 29A(5):753-9. PubMed ID: 8385972
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of multidrug resistance in cancer treatment.
Harris AL; Hochhauser D
Acta Oncol; 1992; 31(2):205-13. PubMed ID: 1352455
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro.
Stahl M; Kasimir-Bauer S; Harstrick A
Anticancer Drugs; 1997 Aug; 8(7):671-6. PubMed ID: 9311443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
